Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 98 of the 98 references it cites were found in a registry or an index.

Searching for perfect sleep: the continuing evolution of GABA A receptor modulators as hypnotics

Nutt, David J, Stahl, S M · 2010 · Journal of Psychopharmacology

Abstract

The non-benzodiazepine GABA A receptor modulators (‘Z-drugs’) — zaleplon, zolpidem, zopiclone and eszopiclone — have become the accepted treatments for insomnia where they are available. However, recent randomized, placebo-controlled trials suggest that, for these drugs, there may be particular efficacy and tolerability profiles and distinct clinical outcomes in specific patient populations. This is particularly apparent when hypnotic/ selective serotonin reuptake inhibitor co-therapy is used to treat patients with co-morbid insomnia and psychiatric disorders, as patient recovery appears to be accelerated and enhanced by some drugs but not others. Emerging evidence of why this should be the case is that these hypnotic drugs may differ significantly from each other in their pharmacodynamic and pharmacokinetic profiles. Functional selectivity for specific GABA A receptor subtypes may determine each drug’s clinical attributes, while the pharmacokinetic characteristics of Z-drugs also determine to a large extent how they perform in the clinic. For example, activity at GABA A alpha 1 receptor subtypes may be associated with sedative effects, whereas activity at alpha 2 and alpha 3 receptor subtypes may be associated with anxiolytic and antidepressant effects. In summary, the distinct clinical outcomes of zaleplon, zolpidem, zopiclone and eszopiclone may be explained by each drug’s unique GABA A receptor subunit selectivity and pharmacokinetic profile. Further investigation of GABA A receptor subtype effects would help to increase understanding of current hypnotic drug effects, while knowledge of each drug’s specific binding profile should enable clinicians to tailor treatment to individual patient’s needs.

Overview

Integrity signals

Registry

Crossref · 10.1177/0269881109106927

Cites

98 of 98 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 98 references

Research works printed but not linked: 18

  1. Brunello N., Abstract Presented at the World Psychiatric Association International Congress (WPA-Florence)
  2. Fava M., Presented at 46th Annual Meeting of the American College of Neuropsychopharmacology
  3. Fava M., Presented at the American Psychiatric Association (APA) 161st Annual Meeting
  4. Harrison NL, 2007, J Clin Psychia, 68, 6
  5. Holbrook AM, 2000, Can Med Ass J, 162, 225
  6. Isawa S., 2000, Nihon Shinkei Seishin Yakurigaku Zasshi, 20, 61
  7. Krystal A., 2008, Euro Neuropsychopharmacol, 18, S517
  8. Krystal A., 2008, Eur Neuropsychopharmacol, 18, S517
  9. Krystal AD, 2007, Journal of Clinical Sleep Medicine, 3, 48
  10. Meda Pharmaceuticals, 2008, Sonata SPC (online)
  11. Ponciano E., 1990, Int Clin Psychopharmacol, 5, 69
  12. Roth T., 2007, Journal of Clinical Sleep Medicine, 3, S7
  13. Sanofi-Aventis., 2007, Ambien (Zolpidem Tartrate) Tablets for Oral Administration Prescribing Information
  14. Sanofi Aventis, 2008, Stilnoct SPC
  15. Sanofi-Aventis, 2008, Zimovane SPC
  16. Scharf MB, 1994, J Clin Psychiat, 55, 192
  17. Sepracor., 2007, Lunesta (Eszopiclone) Tablets Prescribing Information
  18. Vermeeren A., 2002, Sleep, 25, 224

Cited by

See all 168

Metadata

Authors
Nutt, D. J., & Stahl, S. M.
Affiliations
  • Imperial College London (GB)
  • University of California San Diego (US)
Corresponding author
Nutt, David J
Venue
Journal of Psychopharmacology
Published
2009-11-26
Volume
24
Issue
11
Pages
1601-1612
ISSN
  • 0269-8811 (ISSN-L)
  • 1461-7285
OpenAlex
W2008821456
Cited by
163
References
98
Citations by year
2026: 5 · 2025: 11 · 2024: 4 · 2023: 6 · 2022: 10 · 2021: 12 · 2020: 9 · 2019: 11 · 2018: 8 · 2017: 7 · 2016: 11 · 2015: 6 · 2014: 22 · 2013: 14 · 2012: 15
FWCI
1.34
Type
journal article
Language
en
Open access
closed
Licence
journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
Locations
  • Journal of Psychopharmacology (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Social Sciences › Psychology › Experimental and Cognitive Psychology › Sleep and related disorders
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
  • Health Sciences › Medicine › Anesthesiology and Pain Medicine › Anesthesia and Sedative Agents
Keywords
GABA-A receptor modulators, Z-drugs, hypnotics, insomnia, zaleplon, zolpidem, zopiclone, eszopiclone, selective serotonin reuptake inhibitors, psychiatric comorbidity, GABAA receptor subtypes, alpha1 subunit, alpha2 subunit, alpha3 subunit, functional selectivity, pharmacokinetics, sedative effects, anxiolytic effects, antidepressant effects, drug tolerability
MeSH terms
Clinical Trials as Topic, Drug Therapy, Combination, Humans, Hypnotics and Sedatives, Sleep Initiation and Maintenance Disorders, Receptors, GABA-A, Sleep, Comorbidity, Randomized Controlled Trials as Topic, Treatment Outcome

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Searching for perfect sleep: the continuing evolution of GABA A receptor modulators as hypnotics. https://app.cochat.ai/papers/10.1177/0269881109106927
The paper
Nutt, D. J., & Stahl, S. M. (2010). Searching for perfect sleep: the continuing evolution of GABA A receptor modulators as hypnotics. Journal of Psychopharmacology. https://doi.org/10.1177/0269881109106927

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.